Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Brii Biosciences Provides Update on Strategic Clinical Development Progress 2022-12-27 20:00
Ablaze Pharmaceuticals and Yonghe Pharma Initiate Development and Manufacturing Services Agreement for Targeted Radiopharmaceutical Therapies 2022-12-27 10:00
GeneQuantum and WuXi XDC Entered into Strategic Collaboration to Empower Innovative Bioconjugate Development 2022-12-26 23:01
CJ CheilJedang, and Emmyon, Inc. sign a Licensing Agreement to commercialize a dietary supplement with natural extracts for use in significant improvement of skeletal muscle mass and function in humans. 2022-12-26 21:00
Pulnovo Medical will be attending JPM Healthcare Conference 2023 2022-12-24 20:00
JUNIPER BIOLOGICS WINS M&A AWARD 2022 BY ACQUISITION INTERNATIONAL 2022-12-23 09:35
Antengene Announces NDA Submission for XPOVIO® in Macau, Malaysia and Thailand for Relapsed/Refractory Multiple Myeloma and Relapsed/Refractory Diffuse Large B-cell Lymphoma 2022-12-23 08:30
ZIRCON Phase III Renal Cancer Study to be Presented at ASCO GU along with Theranostic Pipeline Advances 2022-12-22 06:04
Nuevocor to Present at Biotech Showcase during JPM week and at Keystone Symposium on Heart Development and Disease 2022-12-21 22:00
Medidata awarded International Innovation Award for Medidata Sensor Cloud 2022-12-21 14:44
QureBio Ltd. to Present its Q-1802 Clinical Phase Ⅰ Data at 2023 ASCO-GI Meetings 2022-12-21 10:30
PeproMene Bio, Inc. Announced Complete Response of The First Patient Treated in Its B-cell Non-Hodgkin Lymphoma (B-NHL) Phase 1 Clinical Trial of PMB-CT01 (BAFFR-CAR T Cells) at City of Hope 2022-12-21 09:00
Ascletis' NASH Drug ASC41(THRβ) Phase II Enrollment is Progressing as Planned 2022-12-21 08:00
WuXi AppTec Named to the 2022 Dow Jones Sustainability World Index 2022-12-21 08:00
Sanisure Announces the Acquisition of a Leading Silicone Extrusion Facility in Twinsburg, Ohio 2022-12-21 00:06
AstraZenca, G42 Healthcare enter strategic partnership to manufacture pharmaceutical products in Abu Dhabi 2022-12-20 23:16
Kira Pharmaceuticals Announces Clearance to Initiate Phase 2 Evaluation of KP104 in IgA Nephropathy (IgAN) and Complement 3 Glomerulopathy (C3G) in China and Australia 2022-12-20 20:00
The Top 8 Best Places to Work in Philippines for 2022 revealed 2022-12-20 19:56
PHASE II/III CLINICAL TRIAL OF SIMCERE'S 3CL-TARGETING ANTI-SARS-COV-2 DRUG CANDIDATE COMPLETE ALL PATIENTS ENROLLMENT 2022-12-20 19:21
Mabwell Bioscience Partners with Binnopharm Group to Market 9MW0113, 9MW0321 and 9MW0311 in Russia and Eurasian Economic Union Countries 2022-12-20 17:00
1 97.5 98.5 99.5 100.5 101.5 415